Kidney Repair Breakthrough Could Transform Future Treatments
A promising kidney repair breakthrough may open new doors for treating kidney disease. Researchers at UCLA discovered that a drug designed for heart recovery also helped damaged kidneys heal in mice. The findings offer hope for millions of people living with kidney problems. As a result, scientists now see new possibilities for future treatments.
A Hidden Barrier to Healing
The research team identified a protein called ENPP1. This protein appears after kidney injury and slows the body’s natural repair process. Scientists found that ENPP1 disrupts energy production inside damaged tissue. Therefore, nearby healthy cells struggle to rebuild the injured area. The team examined kidney samples from people with chronic kidney disease. They discovered much higher ENPP1 levels than those found in healthy tissue.
Next, researchers tested mice with kidney injuries. Some mice could not produce ENPP1, while others had normal levels.
After several weeks, mice without ENPP1 showed stronger recovery. They also had better kidney function and less tissue damage.
Drug Shows Strong Results
Researchers then tested AD-NP1, a drug originally created to repair heart tissue. The treatment blocks ENPP1 and supports natural healing. Seven days after treatment, the mice showed noticeable improvements. Their kidneys worked better and developed less scar tissue.
Scientists also observed increased cell growth in damaged areas. Consequently, the organs repaired themselves more effectively.
The drug belongs to a group called monoclonal antibodies. These laboratory-made proteins target specific molecules with high precision.
AD-NP1 targets ENPP1 without affecting other human proteins. This focused approach may reduce unwanted effects. The U.S. The Food and Drug Administration already approved the drug for Phase 1 heart disease trials. Researchers now hope to launch kidney-focused studies as well.
Although human testing remains necessary, the results look encouraging. If future studies succeed, this discovery could change how doctors treat kidney damage and support long-term organ recovery.
